We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Breakthrough Research Could Eliminate Dental Disease

By HospiMedica International staff writers
Posted on 16 Dec 2010
A new study has deciphered the structure and functional mechanism of the glucansucrase enzyme that is responsible for dental plaque adhering to teeth. More...


Researchers at the University of Groningen (The Netherlandsl) analyzed the glucansucrase enzyme from the lactic acid bacterium Lactobacillus reuteri, which uses it to produce α-glucans, a long-chain sugar formed from the splitting of sucrose into glucose and fructose that facilitates the adhesion of the bacteria to the tooth enamel. The researchers then used protein crystallography to elucidate the three dimensional (3D) structure of the fully active, 1,031-residue fragment encompassing the catalytic and C-terminal domains of the enzyme, both in the native state and in complexes with sucrose and maltose.

The crystallography revealed that the folding mechanism of the protein is unique; the various domains of the enzyme are not formed from a single, linear, amino acid chain but from two parts that assemble via a U-shaped structure. Contrary to the current hypothesis, which assumed that the sucrose splitting and glucose addition were performed by different parts of the enzyme, the model revealed that both activities occur in the same active site of the enzyme. This knowledge, according to the researchers, will stimulate the identification of substances that inhibit the enzyme that can be added to toothpaste, mouthwash, or even sweets, making dental caries a thing of the past. The study was published early online on November 30, 2010, in the Proceedings of the [US] National Academy of Sciences (PNAS).

"The various inhibitors studied not only blocked the glucansucrase, but also the digestive enzyme amylase in our saliva, which is needed to degrade starch,” said study coauthor professor Lubbert Dijkhuizen, PhD, of the laboratory of biophysical chemistry. "We already knew that the two enzymes were similar, but the crystal structure revealed that the active sites are virtually identical. Future inhibitors thus need to be directed towards very specific targets because both enzymes are evolutionary closely related.”

Dental plaque is a biofilm, usually colorless, that is formed by colonizing bacteria trying to attach itself to the smooth surface of the tooth. The film is soft enough to come off if scraped with a fingernail. If not removed it starts to harden within 48 hours; in about 10 days the plaque becomes dental calculus (tartar), rock-hard and difficult to remove. Dental plaque can give rise to dental caries, the localized destruction of the tissues of the tooth by acid produced from the degradation of fermentable sugars by Streptococcus mutans, as well as periodontal problems such as gingivitis and periodontitis.

Related Links:

University of Groningen


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.